Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Hepatix

This article was originally published in The Gray Sheet

Executive Summary

Hepatix: Additional $3 mil. investment is secured from current shareholders including Chase Venture Capital Associates, Alta Partners and Woodland/Essex, the firm reports. Funds will be used for animal testing of the firm's ELAD extracorporeal liver assist device. The privately held company recently received state approval for its San Diego manufacturing facility, paving the way for production of the devices for use in human clinical trials. Studies in humans are anticipated to begin in late 1998, according to the firm...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel